-
1
-
-
8844255630
-
Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction
-
Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002; 32(Suppl 3): 14-23.
-
(2002)
Eur J Clin Invest
, vol.32
, Issue.SUPPL. 3
, pp. 14-23
-
-
Boden, G.1
Shulman, G.I.2
-
2
-
-
0036092239
-
Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
-
McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51: 7-18.
-
(2002)
Diabetes
, vol.51
, pp. 7-18
-
-
McGarry, J.D.1
-
3
-
-
0033927667
-
Cellular mechanisms of insulin resistance
-
Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106: 171-176.
-
(2000)
J Clin Invest
, vol.106
, pp. 171-176
-
-
Shulman, G.I.1
-
4
-
-
0036182137
-
Lipotoxic diseases
-
Unger RH. Lipotoxic diseases. Annu Rev Med 2002; 53: 319-336.
-
(2002)
Annu Rev Med
, vol.53
, pp. 319-336
-
-
Unger, R.H.1
-
5
-
-
0034076660
-
Fuel selection in human skeletal muscle in insulin resistance: A reexamination
-
Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000; 49: 677-683.
-
(2000)
Diabetes
, vol.49
, pp. 677-683
-
-
Kelley, D.E.1
Mandarino, L.J.2
-
6
-
-
0030669094
-
Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612
-
De Fea K, Roth RA. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry 1997; 36: 12939-12947.
-
(1997)
Biochemistry
, vol.36
, pp. 12939-12947
-
-
De Fea, K.1
Roth, R.A.2
-
7
-
-
0035793592
-
Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin
-
Ravichandran LV, Esposito DL, Chen J, Quon MJ. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem 2001; 276: 3543-3549.
-
(2001)
J Biol Chem
, vol.276
, pp. 3543-3549
-
-
Ravichandran, L.V.1
Esposito, D.L.2
Chen, J.3
Quon, M.J.4
-
8
-
-
0038532298
-
A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids
-
Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003; 278: 10297-10303.
-
(2003)
J Biol Chem
, vol.278
, pp. 10297-10303
-
-
Chavez, J.A.1
Knotts, T.A.2
Wang, L.P.3
Li, G.4
Dobrowsky, R.T.5
-
9
-
-
0029853098
-
Lipid mediators of insulin resistance: Ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes
-
Long SD, Pekala PH. Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem J 1996; 319: 179-184.
-
(1996)
Biochem J
, vol.319
, pp. 179-184
-
-
Long, S.D.1
Pekala, P.H.2
-
10
-
-
33847332202
-
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
-
Holland WL, Brozinick JJ, Wang LP, Hawkins ED, Sargent KM, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007; 5: 167-179.
-
(2007)
Cell Metab
, vol.5
, pp. 167-179
-
-
Holland, W.L.1
Brozinick, J.J.2
Wang, L.P.3
Hawkins, E.D.4
Sargent, K.M.5
-
11
-
-
37449020075
-
Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance
-
Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008; 7: 45-56.
-
(2008)
Cell Metab
, vol.7
, pp. 45-56
-
-
Koves, T.R.1
Ussher, J.R.2
Noland, R.C.3
Slentz, D.4
Mosedale, M.5
Ilkayeva, O.6
-
12
-
-
36148937475
-
Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: Implications for metabolic disease
-
Muoio DM, Koves TR. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. Appl Physiol Nutr Metab 2007; 32: 874-883.
-
(2007)
Appl Physiol Nutr Metab
, vol.32
, pp. 874-883
-
-
Muoio, D.M.1
Koves, T.R.2
-
13
-
-
42449152466
-
-
Muoio DM, Koves TR. Lipid-induced metabolic dysfunction in skeletal muscle. Novartis Found Symp 2007; 286: 24-38; discussion 38-46, 162-3, 196-203.
-
Muoio DM, Koves TR. Lipid-induced metabolic dysfunction in skeletal muscle. Novartis Found Symp 2007; 286: 24-38; discussion 38-46, 162-3, 196-203.
-
-
-
-
14
-
-
0025748024
-
Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients
-
Capaldo B, Napoli R, Di Bonito P, Albano G,Sacca L. Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 1991; 14: 191-195.
-
(1991)
Diabetes Res Clin Pract
, vol.14
, pp. 191-195
-
-
Capaldo, B.1
Napoli, R.2
Di Bonito, P.3
Albano, G.4
Sacca, L.5
-
16
-
-
0024268248
-
Interaction of carnitine with insulin-stimulated glucose metabolism in humans
-
Ferrannini E, Buzzigoli G, Bevilacqua S, Boni C, Del Chiaro D, Oleggini M, et al. Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 1988; 255: E946-E952.
-
(1988)
Am J Physiol
, vol.255
-
-
Ferrannini, E.1
Buzzigoli, G.2
Bevilacqua, S.3
Boni, C.4
Del Chiaro, D.5
Oleggini, M.6
-
17
-
-
0034092421
-
Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients
-
Giancaterini A, De Gaetano A, Mingrone G, Gniuli D, Liverani E, Capristo E, et al. Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients. Metabolism 2000; 49: 704-708.
-
(2000)
Metabolism
, vol.49
, pp. 704-708
-
-
Giancaterini, A.1
De Gaetano, A.2
Mingrone, G.3
Gniuli, D.4
Liverani, E.5
Capristo, E.6
-
18
-
-
0033025910
-
L-carnitine improves glucose disposal in type 2 diabetic patients
-
Mingrone G, Greco AV, Capristo E, Benedetti G, Giancaterini A, De Gaetano A, et al. L-carnitine improves glucose disposal in type 2 diabetic patients. J Am Coll Nutr 1999; 18: 77-82.
-
(1999)
J Am Coll Nutr
, vol.18
, pp. 77-82
-
-
Mingrone, G.1
Greco, A.V.2
Capristo, E.3
Benedetti, G.4
Giancaterini, A.5
De Gaetano, A.6
-
19
-
-
34249724327
-
New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle
-
Stephens FB, Constantin-Teodosiu D, Greenhaff PL. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol 2007; 581: 431-444.
-
(2007)
J Physiol
, vol.581
, pp. 431-444
-
-
Stephens, F.B.1
Constantin-Teodosiu, D.2
Greenhaff, P.L.3
-
20
-
-
33845482289
-
An acute increase in skeletal muscle carnitine content alters fuel metabolism in resting human skeletal muscle
-
Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, Greenhaff PL. An acute increase in skeletal muscle carnitine content alters fuel metabolism in resting human skeletal muscle. J Clin Endocrinol Metab 2006; 91: 5013-5018.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 5013-5018
-
-
Stephens, F.B.1
Constantin-Teodosiu, D.2
Laithwaite, D.3
Simpson, E.J.4
Greenhaff, P.L.5
-
21
-
-
3042551249
-
Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation
-
Perdomo G, Commerford SR, Richard AM, Adams SH, Corkey BE, O'Doherty RM, et al. Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J Biol Chem 2004; 279: 27177-27186.
-
(2004)
J Biol Chem
, vol.279
, pp. 27177-27186
-
-
Perdomo, G.1
Commerford, S.R.2
Richard, A.M.3
Adams, S.H.4
Corkey, B.E.5
O'Doherty, R.M.6
-
22
-
-
33947144143
-
CPT I overexpression protects L6E9 muscle cells from fatty acidinduced insulin resistance
-
Sebastian D, Herrero L, Serra D, Asins G, Hegardt FG. CPT I overexpression protects L6E9 muscle cells from fatty acidinduced insulin resistance. Am J Physiol Endocrinol Metab 2007; 292: E677-E686.
-
(2007)
Am J Physiol Endocrinol Metab
, vol.292
-
-
Sebastian, D.1
Herrero, L.2
Serra, D.3
Asins, G.4
Hegardt, F.G.5
-
24
-
-
24044475940
-
The effects of oral L-carnitine treatment on blood lipid metabolism and the body fat content in the diabetic patient
-
Liang Y. The effects of oral L-carnitine treatment on blood lipid metabolism and the body fat content in the diabetic patient. Asia Pac J Clin Nutr 1998; 7: 192-195.
-
(1998)
Asia Pac J Clin Nutr
, vol.7
, pp. 192-195
-
-
Liang, Y.1
-
25
-
-
0037945488
-
The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus
-
Derosa G, Cicero AF, Gaddi A , Mugellini A, Ciccarelli L, Fogari R, et al. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther 2003; 25: 1429-1439.
-
(2003)
Clin Ther
, vol.25
, pp. 1429-1439
-
-
Derosa, G.1
Cicero, A.F.2
Gaddi, A.3
Mugellini, A.4
Ciccarelli, L.5
Fogari, R.6
-
26
-
-
17244363019
-
Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus
-
Rahbar AR, Shakerhosseini R, Saadat N, Taleban F, Pordal A, Gollestan B, et al. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr 2005; 59: 592-596.
-
(2005)
Eur J Clin Nutr
, vol.59
, pp. 592-596
-
-
Rahbar, A.R.1
Shakerhosseini, R.2
Saadat, N.3
Taleban, F.4
Pordal, A.5
Gollestan, B.6
-
27
-
-
33847646640
-
Carnitine revisited: Potential use as adjunctive treatment in diabetes
-
Power RA, Hulver MW, Zhang JY, Dubois J, Marchand RM, Ilkayeva O, et al. Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia 2007; 50: 824-832.
-
(2007)
Diabetologia
, vol.50
, pp. 824-832
-
-
Power, R.A.1
Hulver, M.W.2
Zhang, J.Y.3
Dubois, J.4
Marchand, R.M.5
Ilkayeva, O.6
-
28
-
-
0023033189
-
Dose-dependent lipotropic effect of carnitine in chronic alcoholic rats
-
Rhew TH, Sachan DS. Dose-dependent lipotropic effect of carnitine in chronic alcoholic rats. J Nutr 1986; 116: 2263-2269.
-
(1986)
J Nutr
, vol.116
, pp. 2263-2269
-
-
Rhew, T.H.1
Sachan, D.S.2
-
29
-
-
0026741982
-
Effects of L-carnitine on carbon tetrachloride-induced changes in serum and liver lipids and acylcarnitines
-
Sachan DS, Dodson WL. Effects of L-carnitine on carbon tetrachloride-induced changes in serum and liver lipids and acylcarnitines. J Environ Pathol Toxicol Oncol 1992; 11: 125-129.
-
(1992)
J Environ Pathol Toxicol Oncol
, vol.11
, pp. 125-129
-
-
Sachan, D.S.1
Dodson, W.L.2
-
30
-
-
53749084068
-
Carnitine in metabolic disease: Potential for pharmacological intervention
-
Arduini A, Bonomini M, Savica V, Amato A, Zammit V. Carnitine in metabolic disease: potential for pharmacological intervention. Pharmacol Ther 2008; 120: 149-56.
-
(2008)
Pharmacol Ther
, vol.120
, pp. 149-156
-
-
Arduini, A.1
Bonomini, M.2
Savica, V.3
Amato, A.4
Zammit, V.5
|